Neuroinflammation in sepsis: Sepsis associated delirium

Cardiovascular and Hematological Disorders - Drug Targets

Volumn 15, Issue 1, 2015, Pages 10-18

  Piva, Simone ^a   McCreadie, Victoria A ^b   Latronico, Nicola ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Brain diseases; Delirium; Encephalopathy; Neuroinflammation; Sepsis; Sepsis associated delirium; Sepsis associated encephalopathy; Septic shock

Indexed keywords

BENZODIAZEPINE; CASPASE; DEXMEDETOMIDINE; DOPAMINE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMIC ACID; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; METALLOPROTEINASE; NEURON SPECIFIC ENOLASE; NEUROTRANSMITTER; NORADRENALIN; PROPOFOL; PROTEIN S100B; RILUZOLE; SEROTONIN; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE 1; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; CYTOKINE;

ARTICLE; ATTENTION; BLOOD BRAIN BARRIER; BRAIN CAPILLARY ENDOTHELIAL CELL; BRAIN METABOLISM; CELL ACTIVATION; CENTRAL NERVOUS SYSTEM; CONSCIOUSNESS; DELIRIUM; DISEASE SEVERITY; ELECTROENCEPHALOGRAPHY; HUMAN; INTENSIVE CARE UNIT; MOLECULAR PATHOLOGY; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGULATORY MECHANISM; SEPSIS; SOMATOSENSORY EVOKED POTENTIAL; ANIMAL; CRITICAL ILLNESS; INFLAMMATION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SEPSIS-ASSOCIATED ENCEPHALOPATHY;

ANIMALS; BLOOD-BRAIN BARRIER; CRITICAL ILLNESS; CYTOKINES; HUMANS; INFLAMMATION; INTENSIVE CARE UNITS; NEUROTRANSMITTER AGENTS; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SEPSIS-ASSOCIATED ENCEPHALOPATHY;

EID: 84938421906     PISSN: 1871529X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1871529X15666150108112452     Document Type: Article

References (93)

1. Kaplan, P.W.; Sutter, R. Seeing more clearly through the fog of encephalopathy. J. Clin. Neurophysiol., 2013, 30(5), 431-4.
2. Gofton, T.E.; Young, G.B. Sepsis-associated encephalopathy. Nat. Rev. Neurol., 2012, 8(10), 557-566.
3. Ebersoldt, M.; Sharshar, T.; Annane, D. Sepsis-associated delirium. Intensive Care Med., 2007, 33(6), 941-950.
4. Sprung, C.L.; Peduzzi, P.N.; Shatney, C.H.; Schein, R.M.; Wilson, M.F.; Sheagren, J.N.; Hinshaw, L.B. Impact of encephalopathy on mortality in the sepsis syndrome. The Veterans Administration Systemic Sepsis Cooperative Study Group. Crit. Care Med., 1990, 18(8), 801-806.
5. Eidelman, L.A.; Putterman, D.; Putterman, C.; Sprung, C.L. The spectrum of septic encephalopathy. Definitions, etiologies, and mortalities. JAMA J. Am. Med. Assoc., 1996, 275(6), 470-473.
6. Association A.P. American Psychiatric Association Practice Guidelines for the Treatment of Psychiatric Disorders: Compendium 2006. American Psychiatric Pub; 2006 1600.
7. Peterson, J.F.; Pun, B.T.; Dittus, R.S.; Thomason, J.W.W.; Jackson, J.C.; Shintani, A.K.; Ely, E.W. Delirium and its motoric subtypes: a study of 614 critically ill patients. J. Am. Geriatr. Soc., 2006, 54(3), 479-84.
8. Kelly, K.G.; Zisselman, M.; Cutillo-Schmitter, T.; Reichard, R.; Payne, D.; Denman, S.J. Severity and course of delirium in medically hospitalized nursing facility residents. Am. J. Geriatr. Psychiatry, 2001, 9(1), 72-7.
9. Wilson, J.X.; Young, G.B. Progress in clinical neurosciences: sepsis-associated encephalopathy: evolving concepts. Can. J. Neurol. Sci., 2003, 30(2), 98-105.
10. Zhang, L.; Wang, X.; Ai, Y.; Guo, Q.; Huang, L.; Liu, Z.; Yao, B. Epidemiological features and risk factors of sepsis-associated encephalopathy in intensive care unit patients: 2008-2011. Chin. Med. J. (Engl), 2012, 125(5), 828-831.
11. Young, G.B.; Bolton, C.F.; Austin, T.W.; Archibald Y.M.; Gonder J.; Wells G.A. The encephalopathy associated with septic illness. Clin. Invest. Med., 1990, 13(6), 297-304.
12. Bleck, T.P.; Smith, M.C.; Pierre-Louis, S.J.; Jares, J.J.; Murray, J.; Hansen, C.A. Neurologic complications of critical medical illnesses. Crit. Care Med., 1993, 21(1), 98-103.
13. Sauuh, J.I.; Soares, M.; Teles, J.M.; Cesaso, D.; Raimondin, R.; Nava, V.S.; Blasquez, P.; Ugarte, S.; Ibanez-Guzman, C.; Centeno, J.V.; Laca, M.; Grecco, G, Jimenez, E.; Arias-Rivera, S.; Duenas, C.; Rocha, M.G.; Delprium. Delirium epidemiology in critical care (DECCA): an international study. Crit Care, 2010, 14(6).
14. Inouye, S.K.; van Dyck, C.H.; Alessi, C.A.; Balkin, S.; Siegal, A.P.; Horwitz, R.I. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann. Intern. Med., 1990, 113(12), 941-8.
15. Ely, E.W. Inouye, S.K.; Bernard, G.R.; Gordon, S.; Francis, J.; May, L.; Truman, B. Speroff, T.; Gautan, S.; Margolin, R.; Hart, R.P.; Dittus, R. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA J. Am. Med. Assoc, 2001, 286(21), 2703-2710.
16. Haenggi, M.; Blum, S.; Brechbuehl, R.; Brunello, A.; Jakob, S.M.; Takala, J. Effect of sedation level on the prevalence of delirium when assessed with CAM-ICU and ICDSC. Intensive Care Med., 2013, 39(12), 2171-9.
17. Patel, S.B.; Poston, J.T.; Pohlman, A.; Hall, J.B.; Kress, J.P. Rapidly Reversible, Sedation-related Delirium versus Persistent Delirium in the Intensive Care Unit. Am. J. Respir. Crit. Care Med., 2014, 189(6), 658-65.
18. Van Eijk. M.M.J. et al. Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial. Lancet, 2010, 376(9755), 1829-37.
19. Bergeron, N.; Dubois, M.J.; Dumont, M.; Dial, S.; Skrobik, Y. Intensive Care Delirium Screening Checklist: evaluation of a new screening tool. Intensive Care Med., 2001, 27(5), 859-64.
20. Gusmao-Flores, D.; Figueira Salluh, J.I.; Chalhub, R.A.; Quarantini, L.C. The confusion assessment method for the intensive care unit (CAM-ICU) and intensive care delirium screening checklist (ICDSC) for the diagnosis of delirium: a systematic review and meta-analysis of clinical studies. Crit. Care, 2012, 16(4).
21. Nguyen, D.N.; Spapen, H.; Su, F.; Schiettecatte, J.; Shi, L.; Hachimi-Idrissi S.; Huyghens L. Elevated serum levels of S-100beta protein and neuron-specific enolase are associated with brain injury in patients with severe sepsis and septic shock. Crit. Care Med., 2006, 34(7), 1967-1974.
22. Piazza, O.; Russo, E.; Cotena, S.; Esposito, G.; Tufano, R. Elevated S100B levels do not correlate with the severity of encephalopathy during sepsis. Br. J. Anaesth., 2007, 99(4), 518-521.
23. Hsu, A.A.; Fenton, K.; Weinstein, S.; Carpenter, J.; Dalton, H.; Bell, M.J. Neurological injury markers in children with septic shock. Pediatr Crit care Med. a J. Soc. Crit. Care Med. World Fed. Pediatr Intensive Crit. Care Soc., 2008, 9(3), 245-251.
24. Van den Boogaard, M.; Kox, M.; Quinn, K.L.; van Achterberg, T.; van der Hoeven, J.G.; Schoonhoven, L.; Pickkers, P. Biomarkers associated with delirium in critically ill patients and their relation with long-term subjective cognitive dysfunction; indications for different pathways governing delirium in inflamed and noninflamed patients. Crit. Care, 2011, 15(6), R297.
25. Finelli, P.F.; Uphoff, D.F. Magnetic resonance imaging abnormalities with septic encephalopathy. J. Neurol. Neurosurg. Psychiatry, 2004, 75(8), 1189-1191.
26. Piazza, O.; Cotena, S.; Robertis, E.; Caranci, F.; Tufano, R.; De Robertis, E. Sepsis Associated Encephalopathy Studied by MRI and Cerebral Spinal Fluid S100B Measurement. Neurochem. Res., 2009, 34(7), 1289-1292.
27. Van Eijk, M.M. et al. Routine use of the confusion assessment method for the intensive care unit: a multicenter study. Am. J. Respir. Crit. Care Med., 2011, 184(3), 340-344.
28. Sharshar, T. et al. Brain lesions in septic shock: a magnetic resonance imaging study. Intensive Care Med., 2007, 33(5), 798-806.
29. Polito, A. et al. Pattern of Brain Injury in the Acute Setting of Human Septic Shock. Crit. Care, 2013, 17(5), R204.
30. Young, G.B.; Bolton, C.F.; Archibald, Y.M.; Austin, T.W.; Wells, G.A. The electroencephalogram in sepsis-associated encephalopathy. J. Clin. Neurophysiol. Off Publ Am. Electroencephalogr Soc., 1992, 9(1), 145-152.
31. Kafa, I.M.; Bakirci, S.; Uysal, M.; Kurt, M.A. Alterations in the brain electrical activity in a rat model of sepsis-associated encephalopathy. Brain Res., 2010, 1354, 217-226.
32. Ohnesorge, H.; Bischoff, P.; Scholz, J.; Yekebas, E.; Schulte am Esch, J. Somatosensory evoked potentials as predictor of systemic inflammatory response syndrome in pigs? Intensive Care Med., 2003, 29(5), 801-807.
33. Rosengarten, B.; Hecht, M.; Auch, D.; Ghofrani, H.A.; Schermuly, R.T.; Grimminger, F.; Kaps, M. Microcirculatory Dysfunction in the Brain Precedes Changes in Evoked Potentials in Endotoxin-Induced Sepsis Syndrome in Rats. Cerebrovasc. Dis., 2007, 23(2-3), 140-147.
34. Zauner, C.; Gendo, A.; Kramer, L.; Funk, G.C.; Bauer, E.; Schenk, P.; Ratheiser, K.; Madl, C. Impaired subcortical and cortical sensory evoked potential pathways in septic patients. Crit. Care Med., 2002, 30(5), 1136-1139.
35. Pendlebury, W.W.; Perl, D.P.; Munoz, D.G. Multiple microabscesses in the central nervous system: a clinicopathologic study. J. Neuropathol. Exp. Neurol., 1989, 48(3), 290-300.
36. Brown, R.C.; Morris, A.P.; O’Neil, R.G. Tight junction protein expression and barrier properties of immortalized mouse brain microvessel endothelial cells. Brain Res., 2007, 1130(1), 17-30.
37. Kniesel, U.; Wolburg, H. Tight junctions of the blood-brain barrier. Cell Mol. Neurobiol., 2000, 20(1), 57-76.
38. Nishioku, T.; Dohgu, S.; Takata, F.; Eto, T.; Ishikawa, N.; Kodama, K.B.; Nakagawa, S.; Yamauchi, A.; Kataoka, Y. Detachment of brain pericytes from the basal lamina is involved in disruption of the blood-brain barrier caused by lipopolysaccharide-induced sepsis in mice. Cell Mol. Neurobiol., 2009, 29(3), 309-316.
39. Clawson, C.C.; Hartmann, J.F.; Vernier, R.L. Electron microscopy of the effect of gram-negative endotoxin on the blood-brain barrier. J. Comp. Neurol., 1966, 127(2), 183-198.
40. Jeppsson, B.; Freund, H.R.; Gimmon, Z.; James, J.H.; von Meyenfeldt, M.F.; Fischer, J.E. Blood-brain barrier derangement in sepsis: cause of septic encephalopathy? Am. J. Surg., 1981, 141(1), 136-142.
41. Deng, X.; Wang, X.; Andersson R. Endothelial barrier resistance in multiple organs after septic and nonseptic challenges in the rat. J. Appl. Physiol. (Bethesda, Md 1985), 1995, 78(6), 2052-2061.
42. Vandenbroucke, R.E. et al. Matrix metalloprotease 8-dependent extracellular matrix cleavage at the blood-CSF barrier contributes to lethality during systemic inflammatory diseases. J. Neurosci., 2012, 32(29), 9805-16.
43. Dal-Pizzol, F. et al. Matrix metalloproteinase-2 and metalloproteinase-9 activities are associated with blood-brain barrier dysfunction in an animal model of severe sepsis. Mol. Neurobiol., 2013, 48(1), 62-70.
44. Taccone, F.S.; Su, F.; Pierrakos, C.; He, X.; James, S.; Dewitte, O.; Vincent, J.-L.; De Backer D. Cerebral microcirculation is impaired during sepsis: an experimental study. Crit. Care, 2010, 14(4).
45. Taccone, F.S.; Castanares-Zapatero, D.; Peres-Bota, D.; Vincent, J.-L.; Berre, J.; Melot, C. Cerebral autoregulation is influenced by carbon dioxide levels in patients with septic shock. Neurocrit. Care, 2010, 12(1), 35-42.
46. Bozza, F.A.; Garteiser, P.; Oliveira, M.F.; Doblas, S.; Cranford, R.; Saunders, D.; Jones, I.; Towner, R.A.; Castro-Faria-Neto, H.C. Sepsis-associated encephalopathy: a magnetic resonance imaging and spectroscopy study. J. Cereb. Blood Flow Metab Off J. Int. Soc. Cereb. Blood Flow Metab., 2010, 30(2), 440-448.
47. Roth J.; Harré E.-M.; Rummel C.; Gerstberger R.; Hübschle T. Signaling the brain in systemic inflammation: role of sensory circumventricular organs. Front Biosci a J virtual Libr, 2004, 9, 290-300.
48. Duport, S.; Garthwaite, J. Pathological consequences of inducible nitric oxide synthase expression in hippocampal slice cultures. Neuroscience, 2005, 135(4), 1155-1166.
49. Ikeda-Matsuo, Y.; Ikegaya, Y.; Matsuki, N.; Uematsu, S.; Akira, S.; Sasaki, Y. Microglia-specific expression of microsomal prostaglandin E2 synthase-1 contributes to lipopolysaccharideinduced prostaglandin E2 production. J. Neurochem., 2005, 94(6), 1546-1558.
50. Banks, W.A.; Kastin, A.J.; Durham, D.A. Bidirectional transport of interleukin-1 alpha across the blood-brain barrier. Brain Res Bull, 1989, 23(6), 433-437.
51. Banks, W.A.; Kastin, A.J.; Gutierrez E.G. Penetration of interleukin-6 across the murine blood-brain barrier. Neurosci. Lett., 1994, 179(1-2), 53-56.
52. McCann, S.M.; Kimura, M.; Karanth, S.; Yu, W.H.; Mastronardi, C.A.; Rettori V. The mechanism of action of cytokines to control the release of hypothalamic and pituitary hormones in infection. Ann. N Y Acad. Sci., 2000, 917, 4-18.
53. Pan, W.; Banks, W.A.; Fasold, M.B.; Bluth, J.; Kastin, A.J. Transport of brain-derived neurotrophic factor across the bloodbrain barrier. Neuropharmacology, 1998, 37(12), 1553-1561.
54. Aloisi, F. Immune function of microglia. Glia, 2001, 36(2), 165-79.
55. Deng, Y.; Lu, J.; Sivakumar, V.; Ling, E.A.; Kaur, C. Amoeboid microglia in the periventricular white matter induce oligodendrocyte damage through expression of proinflammatory cytokines via MAP kinase signaling pathway in hypoxic neonatal rats. Brain Pathol., 2008, 18(3), 387-400.
56. Deng, Y.Y.; Lu, J.; Ling, E.-A.; Kaur, C. Microglia-derived macrophage colony stimulating factor promotes generation of proinflammatory cytokines by astrocytes in the periventricular white matter in the hypoxic neonatal brain. Brain Pathol., 2010, 20(5), 909-25.
57. Verma, S.; Nakaoke, R.; Dohgu, S.; Banks, W.A. Release of cytokines by brain endothelial cells: A polarized response to lipopolysaccharide. Brain Behav, Immun., 2006, 20(5), 449-55.
58. Van Gool, W.A.; van de Beek, D.; Eikelenboom, P. Systemic infection and delirium: when cytokines and acetylcholine collide. Lancet, 2010, 375(9716), 773-775.
59. Guillery, R.W.; Feig, S.L.; Van Lieshout, D.P. Connections of higher order visual relays in the thalamus: a study of corticothalamic pathways in cats. J. Comp. Neurol., 2001, 438(1), 66-85.
60. Stanford, L.R.; Friedlander, M.J.; Sherman, S.M. Morphology of physiologically identified W-cells in the C laminae of the cat’s lateral geniculate nucleus. J. Neurosci., 1981, 1(6), 578-584.
61. Elderfield, A.J.; Bolton, C.; Flower, R.J. Lipocortin 1 (annexin 1) immunoreactivity in the cervical spinal cord of Lewis rats with acute experimental allergic encephalomyelitis. J. Neurol. Sci., 1993, 119(2), 146-153.
62. Paulson, O.B.; Newman, E.A. Does the release of potassium from astrocyte endfeet regulate cerebral blood flow? Science (80-), 1987, 237(4817), 896-898.
63. Tsacopoulos, M.; Magistretti P.J. Metabolic coupling between glia and neurons. J. Neurosci., 1996, 16(3), 877-885.
64. Janzer, R.C. The blood-brain barrier: cellular basis. J. Inherit. Metab. Dis., 1993, 16(4), 639-647.
65. Janzer, R.C.; Raff, M.C. Astrocytes induce blood-brain barrier properties in endothelial cells. Nature, 1987, 325(6101), 253-257.
66. Maier, S.F.; Goehler, L.E.; Fleshner M.; Watkins L.R. The role of the vagus nerve in cytokine-to-brain communication. Ann. NY Acad. Sci., 1998, 840, 289-300.
67. Cipriani, A. et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments metaanalysis. Lancet, 2009, 373(9665), 746-758.
68. Pandharipande, P.P.; Morandi, A.; Adams, J.R.; Girard, T.D.; Thompson, J.L.; Shintani, A.K.; Ely, E.W. Plasma tryptophan and tyrosine levels are independent risk factors for delirium in critically ill patients. Intensive Care Med., 2009, 35(11), 1886-1892.
69. Freund, H.R.; Ryan, Jr. J.A.; Fischer, J.E. Amino acid derangements in patients with sepsis: treatment with branched chain amino acid rich infusions. Ann. Surg., 1978, 188(3), 423-430.
70. Sprung, C.L.; Cerra, F.B.; Freund, H.R.; Schein, R.M.; Konstantinides, F.N.; Marcial, E.H.; Pena, M. Amino acid alterations and encephalopathy in the sepsis syndrome. Crit. Care Med., 1991, 19(6), 753-757.
71. Basler, T.; Meier-Hellmann, A.; Bredle, D.; Reinhart, K. Amino acid imbalance early in septic encephalopathy. Intensive Care Med., 2002, 28(3), 293-298.
72. Toklu. H.Z.; Uysal. M.K.; Kabasakal. L.; Sirvanci, S.; Ercan, F.; Kaya, M. The effects of riluzole on neurological, brain biochemical, and histological changes in early and late term of sepsis in rats. J. Surg. Res., 2009, 152(2), 238-248.
73. Galley, H.F. Oxidative stress and mitochondrial dysfunction in sepsis. Br. J. Anaesth., 2011, 107(1), 57-64.
74. Exline, M.C.; Crouser, E.D. Mitochondrial dysfunction during sepsis: still more questions than answers. Crit. Care Med., 2011, 39(5), 1216-7.
75. Huang, L.-J.; Hsu, C.; Tsai, T.-N.; Wang, S.-J.; Yang, R.-C. Suppression of mitochondrial ATPase inhibitor protein (IF1) in the liver of late septic rats. Biochim. Biophys. Acta, 2007, 1767(7), 888-96.
76. Kirkebøen, K.A.; Strand, O.A. The role of nitric oxide in sepsis--an overview. Acta Anaesthesiol. Scand., 1999, 43(3), 275-88.
77. Hinkelbein, J.; Feldmann, Jr. R.E.; Peterka, A.; Schubert, C.; Schelshorn, D.; Maurer, M.H.; Kalenka, A. Alterations in cerebral metabolomics and proteomic expression during sepsis. Curr. Neurovasc. Res., 2007, 4(4), 280-288.
78. Barr, J. et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit. Care Med., 2013, 41(1), 263-306.
79. Hall, J.B.; Schweickert, W.; Kress, J.P. Role of analgesics, sedatives, neuromuscular blockers, and delirium. Crit. Care Med., 2009, 37(10), S416-21.
80. Reade, M.C.; Finfer, S. Sedation and delirium in the intensive care unit. N. Engl. J. Med., 2014, 370(5), 444-54.
81. Brummel N.E.; Girard T.D. Preventing delirium in the intensive care unit. Crit. Care Clin., 2013, 29(1), 51-65.
82. Morandi, A.; Brummel, N.E.; Ely, E.W. Sedation, delirium and mechanical ventilation: the "ABCDE" approach. Curr. Opin. Crit. Care, 2011, 17(1), 43-9.
83. Vasilevskis, E.E.; Ely, E.W.; Speroff, T.; Pun, B.T.; Boehm, L.; Dittus, R.S. Reducing iatrogenic risks: ICU-acquired delirium and weakness--crossing the quality chasm. Chest, 2010, 138(5), 1224-33.
84. Girard, T.D. et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet, 2008, 371(9607), 126-34.
85. Silva, P.L.; Pelosi, P.; Rocco, P.R.M. Fluids in acute respiratory distress syndrome: pros and cons. Curr. Opin. Crit. Care, 2014, 20(1), 104-12.
86. Tropea, J.; Slee, J.-A.; Brand, C.A.; Gray, L.; Snell, T. Clinical practice guidelines for the management of delirium in older people in Australia. Australas J. Ageing, 2008, 27(3), 150-6.
87. Devlin, J.W.; Roberts, R.J.; Fong, J.J.; Skrobik, Y.; Riker, R.R.; Hill, N.S.; Robbins, T.; Garpestad, E. Efficacy and safety of quetiapine in critically ill patients with delirium: A prospective, multicenter, randomized, double-blind, placebo-controlled pilot study*. Crit. Care Med. 2010, 38(2), 419-427.
88. Page, V.J.; Ely, E.W.; Gates, S.; Zhao, X.B.; Alce, T.; Shintani, A.; Jackson, J.; Perkins, G.D.; McAuley, D.F. Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebocontrolled trial. Lancet Respir. Med., 2013, 1(7), 515-23.
89. Otero, R.M. et al. Early goal-directed therapy in severe sepsis and septic shock revisited: concepts, controversies, and contemporary findings. Chest, 2006, 130(5), 1579-95.
90. Ely, E.W.; Shintani, A.; Truman, B.; Speroff, T.; Gordon, S.M.; Harrell, Jr. F.E.; Inouye, S.K.; Bernard, G.R.; Dittus R.S. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA, 2004, 291(14), 1753-1762.
91. Hopkins, R.O.; Jackson, J.C. Long-term neurocognitive function after critical illness. Chest, 2006, 130(3), 869-878.
92. Iwashyna, T.J.; Ely, E.W.; Smith, D.M.; Langa, K.M. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA, 2010, 304(16), 1787-94.
93. Brummel, N.E.; Jackson, J.C.; Pandharipande, P.P.; Thompson, J.L.; Shintani, A.K.; Dittus, R.S.; Gill, T.M.; Bernard, G.R.; Ely, E.W.; Girard, T.D. Delirium in the ICU and subsequent long-term disability among survivors of mechanical ventilation. Crit. Care Med., 2014, 42(2), 369-77.